AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection

IF 3.3 4区 医学 Q3 ENGINEERING, BIOMEDICAL
Ulviye Ki̇li̇mci̇, Baha Öndeş, Yüksel Şahi̇n, Murat Uygun, Deniz Aktaş Uygun
{"title":"AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection","authors":"Ulviye Ki̇li̇mci̇,&nbsp;Baha Öndeş,&nbsp;Yüksel Şahi̇n,&nbsp;Murat Uygun,&nbsp;Deniz Aktaş Uygun","doi":"10.1007/s10544-025-00775-w","DOIUrl":null,"url":null,"abstract":"<div><p>In this study, a novel immunosensor for carcinoembryonic antigen (CEA) determination was designed, and the synergistic effect of zero-dimensional gold nanoparticles and two-dimensional nanomaterials TiS<sub>2</sub> was investigated. In this regard, gold nanoparticles were electrochemically deposited on the surface of the screen-printed electrode (SPE), with MAU employed as a surface activation agent following the insertion of TiS<sub>2</sub> nanosheets. The anti-CEA was attached to the surface through EDC/NHS chemistry, utilizing the carboxy end of MUA attached to AuNPs and TiS<sub>2</sub> nanosheets. The resulting structure was subsequently protected by Nafion, and non-specific binding to the surface was prevented by the addition of bovine serum albumin (BSA). In a similar manner, an immunosensor was formulated that did not contain TiS₂. CEA quantification was executed via an impedimetric approach. A comprehensive evaluation of the impedimetric outcomes indicated that the immunosensor comprising AuNPs alone was inadequate in achieving an accurate measurement range. Nevertheless, an immunosensor with a very low concentration range (1-100 pg/mL) and a low limit of detection (LOD, 0.21 pg/mL) value could be prepared through the synergistic effect of TiS<sub>2</sub>. The AuNPs-TiS<sub>2</sub>-based immunosensor exhibits both high selectivity and reproducibility. Furthermore, the immunosensor exhibits noteworthy storage stability, thus making it well-suited for the quantification of CEA in biological specimens, such as blood. The properties described herein serve to substantiate the hypothesis that the Au-TiS<sub>2</sub>-based immunosensor is a promising candidate for clinical applications.</p></div>","PeriodicalId":490,"journal":{"name":"Biomedical Microdevices","volume":"27 4","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Microdevices","FirstCategoryId":"5","ListUrlMain":"https://link.springer.com/article/10.1007/s10544-025-00775-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, a novel immunosensor for carcinoembryonic antigen (CEA) determination was designed, and the synergistic effect of zero-dimensional gold nanoparticles and two-dimensional nanomaterials TiS2 was investigated. In this regard, gold nanoparticles were electrochemically deposited on the surface of the screen-printed electrode (SPE), with MAU employed as a surface activation agent following the insertion of TiS2 nanosheets. The anti-CEA was attached to the surface through EDC/NHS chemistry, utilizing the carboxy end of MUA attached to AuNPs and TiS2 nanosheets. The resulting structure was subsequently protected by Nafion, and non-specific binding to the surface was prevented by the addition of bovine serum albumin (BSA). In a similar manner, an immunosensor was formulated that did not contain TiS₂. CEA quantification was executed via an impedimetric approach. A comprehensive evaluation of the impedimetric outcomes indicated that the immunosensor comprising AuNPs alone was inadequate in achieving an accurate measurement range. Nevertheless, an immunosensor with a very low concentration range (1-100 pg/mL) and a low limit of detection (LOD, 0.21 pg/mL) value could be prepared through the synergistic effect of TiS2. The AuNPs-TiS2-based immunosensor exhibits both high selectivity and reproducibility. Furthermore, the immunosensor exhibits noteworthy storage stability, thus making it well-suited for the quantification of CEA in biological specimens, such as blood. The properties described herein serve to substantiate the hypothesis that the Au-TiS2-based immunosensor is a promising candidate for clinical applications.

用于癌胚抗原(CEA)检测的AuNPs-TiS2修饰的无标记超灵敏电化学免疫传感器
本研究设计了一种检测癌胚抗原(CEA)的新型免疫传感器,并研究了零维金纳米粒子与二维纳米材料TiS2的协同作用。在这方面,金纳米颗粒被电化学沉积在丝网印刷电极(SPE)的表面,在TiS2纳米片的插入后,MAU被用作表面活性剂。通过EDC/NHS化学,利用MUA的羧基端连接到AuNPs和TiS2纳米片上,将抗cea附着在表面。所得到的结构随后被Nafion保护,并通过添加牛血清白蛋白(BSA)来防止与表面的非特异性结合。以类似的方式,配制了一种不含TiS₂的免疫传感器。CEA定量采用阻抗法。对阻抗结果的综合评估表明,仅含有AuNPs的免疫传感器不足以实现准确的测量范围。然而,通过TiS2的协同作用,可以制备出浓度范围极低(1-100 pg/mL)、检测限低(LOD, 0.21 pg/mL)的免疫传感器。基于aunps - tis2的免疫传感器具有高选择性和可重复性。此外,该免疫传感器具有显著的储存稳定性,因此非常适合于生物标本(如血液)中CEA的定量。本文描述的性质有助于证实假设,即基于au - tis2的免疫传感器是临床应用的有希望的候选者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomedical Microdevices
Biomedical Microdevices 工程技术-工程:生物医学
CiteScore
6.90
自引率
3.60%
发文量
32
审稿时长
6 months
期刊介绍: Biomedical Microdevices: BioMEMS and Biomedical Nanotechnology is an interdisciplinary periodical devoted to all aspects of research in the medical diagnostic and therapeutic applications of Micro-Electro-Mechanical Systems (BioMEMS) and nanotechnology for medicine and biology. General subjects of interest include the design, characterization, testing, modeling and clinical validation of microfabricated systems, and their integration on-chip and in larger functional units. The specific interests of the Journal include systems for neural stimulation and recording, bioseparation technologies such as nanofilters and electrophoretic equipment, miniaturized analytic and DNA identification systems, biosensors, and micro/nanotechnologies for cell and tissue research, tissue engineering, cell transplantation, and the controlled release of drugs and biological molecules. Contributions reporting on fundamental and applied investigations of the material science, biochemistry, and physics of biomedical microdevices and nanotechnology are encouraged. A non-exhaustive list of fields of interest includes: nanoparticle synthesis, characterization, and validation of therapeutic or imaging efficacy in animal models; biocompatibility; biochemical modification of microfabricated devices, with reference to non-specific protein adsorption, and the active immobilization and patterning of proteins on micro/nanofabricated surfaces; the dynamics of fluids in micro-and-nano-fabricated channels; the electromechanical and structural response of micro/nanofabricated systems; the interactions of microdevices with cells and tissues, including biocompatibility and biodegradation studies; variations in the characteristics of the systems as a function of the micro/nanofabrication parameters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信